Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB) (2022)
- Authors:
- Autor USP: FEITOSA, MARLEY RIBEIRO - FMRP
- Unidade: FMRP
- DOI: 10.1186/s12876-022-02341-7
- Subjects: ANTICORPOS MONOCLONAIS; COLITE ULCERATIVA; ESTUDOS PROSPECTIVOS
- Keywords: Adalimumab; Anti-TNF therapy; Clinical remission; Infliximab; Ulcerative colitis
- Language: Inglês
- Imprenta:
- Source:
- Título: BMC Gastroenterology
- ISSN: 1471-230X
- Volume/Número/Paginação/Ano: v. 22, art. 268, p. 1-12, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SASSAKI, ligia Yukie et al. Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB). BMC Gastroenterology, v. 22, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12876-022-02341-7. Acesso em: 26 dez. 2025. -
APA
Sassaki, ligia Y., Magro, D. O., Saad-Hossne, R., Baima, J. P., Flores, C., Correia, L. M., et al. (2022). Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB). BMC Gastroenterology, 22, 1-12. doi:10.1186/s12876-022-02341-7 -
NLM
Sassaki ligia Y, Magro DO, Saad-Hossne R, Baima JP, Flores C, Correia LM, Celani LMS, Ferrari M de L de A, Zacharias P, Feitosa MR, Santos CHM dos, Lins Neto MÀ de F. Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB) [Internet]. BMC Gastroenterology. 2022 ; 22 1-12.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1186/s12876-022-02341-7 -
Vancouver
Sassaki ligia Y, Magro DO, Saad-Hossne R, Baima JP, Flores C, Correia LM, Celani LMS, Ferrari M de L de A, Zacharias P, Feitosa MR, Santos CHM dos, Lins Neto MÀ de F. Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB) [Internet]. BMC Gastroenterology. 2022 ; 22 1-12.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1186/s12876-022-02341-7 - Análise do conhecimento sobre diagnóstico e prevenção do câncer colorretal em pacientes do Sistema Único de Saúde e alunos da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
- Anti-TNF therapy for Ulcerative Colitis in Brazil: a comparative real-world national multicentric study from the Brazilian Study Group of IBD (GEDIIB)
- Cutaneous vasculitis associated with vedolizumab in ulcerative colitis [Carta]
- Rate of conversion to an open procedure. [Carta]: Is it really reduced in robotic colorectal surgery ?
- Segmental colectomy [Carta]: an alternative for ulcerative colitis in endoscopic remission?
- Comment on: quality of colonoscopy. [Carta]: are gastroenterologists really better ?
- Postoperative complications and stoma rates after laparoscopic resection of deep infiltrating endometriosis with bowel involvement
- Anti-TNF-therapy-induced leukocytoclastic vasculitis: a rare complication in IBD patients
- Cross-cultural translation and validation of the quality of life disk in inflammatory bowel diseases “IBD Disk” into portuguese
- Prevalence and predictive factors associated with positivity of Sars-Cov-2 serological markers in patients with inflammatory bowel disease at an ibd referral center
Informações sobre o DOI: 10.1186/s12876-022-02341-7 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003261076.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
